Key terms
About AZTA
Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AZTA news
Apr 08
4:05pm ET
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
Apr 04
8:20am ET
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Apr 04
5:03am ET
Azenta initiated with a Hold at Jefferies
Mar 28
5:35am ET
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
Mar 14
1:25pm ET
Azenta: A Strong Buy on Robust Financial Guidance and Market-Leading Position
Mar 14
9:02am ET
Azenta Announces Investor Day to Share Company Insights
Mar 07
5:25am ET
Buy Rating Affirmed: Azenta’s Strong Financial Outlook and Strategic Growth Trajectory
Feb 08
5:30am ET
Analysts Offer Insights on Healthcare Companies: Azenta (AZTA), Neurocrine (NBIX) and McKesson (MCK)
Feb 07
11:15pm ET
Strong Buy Rating for Azenta, Inc. Amid Growth and Strategic Initiatives
Feb 07
4:13pm ET
Azenta backs FY24 adjusted EPS view 19c-29c, consensus 25c
Feb 07
4:11pm ET
Azenta reports Q1 adjusted cont ops EPS 2c, consensus (3c)
Feb 01
8:10am ET
Azenta price target raised to $79 from $61 at B. Riley
Jan 22
1:18pm ET
Optimistic Financial Outlook for Azenta: A Strong Buy Rating with Increased Target Price
No recent press releases are available for AZTA
AZTA Financials
Key terms
Ad Feedback
AZTA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AZTA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range